Copyright Reports & Markets. All rights reserved.

Global Asthma Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Asthma Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Inhalation
      • 1.4.3 Parenteral
      • 1.4.4 Oral
    • 1.5 Market by Application
      • 1.5.1 Global Asthma Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Asthma Therapeutics Market Size
    • 2.2 Asthma Therapeutics Growth Trends by Regions
      • 2.2.1 Asthma Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Asthma Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Asthma Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Asthma Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Asthma Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Asthma Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Asthma Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Asthma Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Asthma Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Asthma Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Asthma Therapeutics Market Size (2014-2019)
    • 5.2 Asthma Therapeutics Key Players in United States
    • 5.3 United States Asthma Therapeutics Market Size by Type
    • 5.4 United States Asthma Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Asthma Therapeutics Market Size (2014-2019)
    • 6.2 Asthma Therapeutics Key Players in Europe
    • 6.3 Europe Asthma Therapeutics Market Size by Type
    • 6.4 Europe Asthma Therapeutics Market Size by Application

    7 China

    • 7.1 China Asthma Therapeutics Market Size (2014-2019)
    • 7.2 Asthma Therapeutics Key Players in China
    • 7.3 China Asthma Therapeutics Market Size by Type
    • 7.4 China Asthma Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Asthma Therapeutics Market Size (2014-2019)
    • 8.2 Asthma Therapeutics Key Players in Japan
    • 8.3 Japan Asthma Therapeutics Market Size by Type
    • 8.4 Japan Asthma Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Asthma Therapeutics Market Size (2014-2019)
    • 9.2 Asthma Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Asthma Therapeutics Market Size by Type
    • 9.4 Southeast Asia Asthma Therapeutics Market Size by Application

    10 India

    • 10.1 India Asthma Therapeutics Market Size (2014-2019)
    • 10.2 Asthma Therapeutics Key Players in India
    • 10.3 India Asthma Therapeutics Market Size by Type
    • 10.4 India Asthma Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Asthma Therapeutics Market Size (2014-2019)
    • 11.2 Asthma Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Asthma Therapeutics Market Size by Type
    • 11.4 Central & South America Asthma Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 AstraZeneca
      • 12.1.1 AstraZeneca Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Asthma Therapeutics Introduction
      • 12.1.4 AstraZeneca Revenue in Asthma Therapeutics Business (2014-2019)
      • 12.1.5 AstraZeneca Recent Development
    • 12.2 Boehringer Ingelheim
      • 12.2.1 Boehringer Ingelheim Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Asthma Therapeutics Introduction
      • 12.2.4 Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2014-2019)
      • 12.2.5 Boehringer Ingelheim Recent Development
    • 12.3 F. Hoffmann-La Roche
      • 12.3.1 F. Hoffmann-La Roche Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Asthma Therapeutics Introduction
      • 12.3.4 F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2014-2019)
      • 12.3.5 F. Hoffmann-La Roche Recent Development
    • 12.4 GSK
      • 12.4.1 GSK Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Asthma Therapeutics Introduction
      • 12.4.4 GSK Revenue in Asthma Therapeutics Business (2014-2019)
      • 12.4.5 GSK Recent Development
    • 12.5 Merck
      • 12.5.1 Merck Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Asthma Therapeutics Introduction
      • 12.5.4 Merck Revenue in Asthma Therapeutics Business (2014-2019)
      • 12.5.5 Merck Recent Development
    • 12.6 Horizon Pharma
      • 12.6.1 Horizon Pharma Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Asthma Therapeutics Introduction
      • 12.6.4 Horizon Pharma Revenue in Asthma Therapeutics Business (2014-2019)
      • 12.6.5 Horizon Pharma Recent Development
    • 12.7 Mitsubishi Tanabe Pharma
      • 12.7.1 Mitsubishi Tanabe Pharma Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Asthma Therapeutics Introduction
      • 12.7.4 Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2014-2019)
      • 12.7.5 Mitsubishi Tanabe Pharma Recent Development
    • 12.8 Sanofi
      • 12.8.1 Sanofi Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Asthma Therapeutics Introduction
      • 12.8.4 Sanofi Revenue in Asthma Therapeutics Business (2014-2019)
      • 12.8.5 Sanofi Recent Development
    • 12.9 Mundipharma
      • 12.9.1 Mundipharma Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Asthma Therapeutics Introduction
      • 12.9.4 Mundipharma Revenue in Asthma Therapeutics Business (2014-2019)
      • 12.9.5 Mundipharma Recent Development
    • 12.10 Nycomed
      • 12.10.1 Nycomed Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Asthma Therapeutics Introduction
      • 12.10.4 Nycomed Revenue in Asthma Therapeutics Business (2014-2019)
      • 12.10.5 Nycomed Recent Development
    • 12.11 Kissei Pharmaceutical
    • 12.12 ALK-Abello
    • 12.13 Array BioPharma
    • 12.14 SAMA Pharmaceuticals
    • 12.15 Whanin Pharmaceutical

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Asthma Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Asthma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Asthma Therapeutics development in United States, Europe and China.

      The key players covered in this study
      AstraZeneca
      Boehringer Ingelheim
      F. Hoffmann-La Roche
      GSK
      Merck
      Horizon Pharma
      Mitsubishi Tanabe Pharma
      Sanofi
      Mundipharma
      Nycomed
      Kissei Pharmaceutical
      ALK-Abello
      Array BioPharma
      SAMA Pharmaceuticals
      Whanin Pharmaceutical

      Market segment by Type, the product can be split into
      Inhalation
      Parenteral
      Oral

      Market segment by Application, split into
      Hospitals
      Clinics

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Asthma Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Asthma Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Asthma Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now